Objective The latest model of vibration-controlled transient elastography (VCTE) automatically selects M or XL probe according to patients’ body built. We aim to test the application of a unified interpretation of VCTE results with probes appropriate for the body mass index (BMI) and hypothesise that this approach is not affected by hepatic steatosis.
Design We prospectively recruited 496 patients with non-alcoholic fatty liver disease who underwent VCTE by both M and XL probes within 1 week before liver biopsy.
Results 391 (78.8%) and 433 (87.3%) patients had reliable liver stiffness measurement (LSM) (10 successful acquisitions and IQR:median ratio ≤0.30) by M and XL probes, respectively (p<0.001). The area under the receiver operating characteristic curves was similar between the two probes (0.75–0.88 for F2–4, 0.83–0.91 for F4). When used in the same patient, LSM by XL probe was lower than that by M probe (mean difference 2.3 kPa). In contrast, patients with BMI ≥30 kg/m2 had higher LSM regardless of the probe used. When M and XL probes were used in patients with BMI <30 and ≥30 kg/m2, respectively, they yielded nearly identical median LSM at each fibrosis stage and similar diagnostic performance. Severe steatosis did not increase LSM or the rate of false-positive diagnosis by XL probe.
Conclusion High BMI but not severe steatosis increases LSM. The same LSM cut-offs can be used without further adjustment for steatosis when M and XL probes are used according to the appropriate BMI.
- liver cirrhosis
- liver biopsy
- fatty liver
- nonalcoholic steatohepatitis
- hepatic fibrosis
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors VW-SW, WKC and VdL designed the study. VW-SW, MI, GL-HW, SS, AW-HC, WM, SS-TS, JF, BLB and VdL collected patient data. AW-HC and BLB performed histological assessment. HL-YC and VdL provided administrative support. VW-SW and VdL performed statistical analysis and drafted the manuscript. All authors approved the final version of the manuscript.
Funding This project was partially supported by a grant from the Research Grant Council of the Hong Kong SAR Government (Project Ref 14108916).
Competing interests VW-SW, GL-HW, HL-YC and VdL have served as speakers for Echosens.
Patient consent Obtained.
Ethics approval The study protocol was approved by the institutional review boards of Bordeaux University Hospital, France and Prince of Wales Hospital, Hong Kong.
Provenance and peer review Not commissioned; externally peer reviewed.